Abstract
The existence of cell surface receptors for extracellular adenine nucleotides in mammalian cells has been postulated for decades (Burn-stock, 1972), based on scores of reports on diverse responses to these molecules in a wide variety of tissues and cell types (Dubyak and El-Moatassim, 1993). Pharmacological studies have provided evidence for the expression of two major types of nucleotide receptors: those belonging to the G protein-coupled receptor family and those belonging to the ligand-gated ion channel family. Nucleotide receptors (P2 purinergic receptors) are distinct from P1 receptors for adenosine, and, from results of earlier studies, were thought to be selective for purine nucleotides, in particular adenosine 5′-triphosphate (ATP), adenosine 5′-diphosphate (ADP) and various analogs, including 2MeSATP, α,β-MeATP, and β,γ-MeATP. Recent studies have demonstrated that uridine nucleotides are equally or more effective than adenine nucleotides in activating several G protein-coupled P2 receptor subtypes, raising a question as to the appropriateness of referring to this family of receptors as “purinergic.” Nonetheless, nucleotide receptors have retained the designation “P2,” which now refers to both their purine- and/or pyrimidine-based nucleotide agonists.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akbar, G. K. M., Dasari, V. R., Webb, T. E., Ayyanathan, K., Pillarisetti, K., Sandhu, A. K., Athwal, R. S., Daniel, J. L., Ashby, B., Barnard, E. A., and Kunapuli, S. P. (1996) Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells. J. Biol. Chem. 271, 18, 363–418, 367.
Ayyanathan, K., Webb, T. E., Sandhu, A. K., Athwal, R. S., Barnard, E. A., and Kunapuli, S. P. (1996) Cloning and chromosomal localization of the human P2Y1 purinoceptor. Biochem. Biophys. Res. Commun. 218, 783–788.
Boarder, M. R., Weisman, G. A., Turner, J. T., and Wilkinson, G. F. (1994) G protein-protein-coupled P2 purinoceptors: from molecular biology to functional responses. Tr. Pharmacol. Sci. 16, 133–138.
Bowler, W. B., Birch, M. A., Gallagher, J. A., and Bilbe, G. (1995) Identification and cloning of human P2u purinoceptor present in osteoclastoma, bone, and osteoblasts. J. Bone Mineral Res. 10, 1137–1145.
Boyer, J. L. and Harden, T. K. (1989) Irreversible activation of phospholipase C-coupled P2Y-purinergic receptors by 3′-O-(4-benzoyl) benzoyl adenosine 5′-tri-phosphate. Mol. Pharmacol. 36, 831–835.
Buell, G., Collo, G., and Rassendren, F. (1996) P2X receptors: an emerging channel family. Eur. J. Neurosci. 8, 2221–2228.
Burnstock, G. (1972) Purinergic nerves. Pharmacol. Rev. 24, 509–581.
Burnstock, G. and Kennedy, C. (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen. Pharmacol. 16, 433–440.
Burnstock, G. and King, B. F. (1996) The numbering of cloned P2 purinoceptors. Drug Dev.Res. 38, 67–71.
Camden, J. M., Weisman, G. A., and Turner, J. T. (1997) Up-regulation of P2Y2 nucleotide receptor expression and activity in rat submandibular gland cells during short-term culture. Am. J. Physiol., in press.
Chang, K., Hanaoka, K., Kumada, M., and Takuwa, Y. (1995) Molecular cloning and functional analysis of a novel P2 nucleotide receptor. J. Biol. Chem. 270, 26, 152–226, 158.
Charlton, S. J., Brown, C. A., Weisman, G. A., Turner, J. T., Erb, L., and Boarder, M. R. (1996a) PPADS and suramin as antagonists at cloned P2Y-and P2u-purino-ceptors. Br. J. Pharmacol. 118, 704–710.
Charlton, S. J., Brown, C. A., Weisman, G. A., Turner, J. T., Erb, L., and Boarder, M. R. (1996b) Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS insensitive response to UTP. Br. J. Pharmacol. 119, 1301–1303.
Chen, Z.-P., Krull, N., Xu, S., Levy, A., and Lightman, S. L. (1996) Molecular cloning and functional characterization of a rat pituitary G protein-coupled adenosine triphosphate (ATP) receptor. Endocrinology 137, 1833–1840.
Colman, R.W. (1990) Aggregin: a platelet ADP receptor that mediates activation. FASEB J. 4, 1425–1435.
Communi, D., Pirotton, S., Parmentier, M., and Boeynaems, J.-M. (1995) Cloning and functional expression of a human uridine nucleotide receptor. J. Biol. Chem. 270, 30, 849–930, 852.
Communi, D., Parmentier, M., and Boeynaems, J.-M. (1996) Cloning, functional expression and tissue distribution of the human P2Y6 receptor. Biochem. Biophys. Res. Commun. 222, 303–308.
Dohlman, H. G., Thorner, J., Caron, M. G., and Lefkowitz, R. J. (1991) Model systems for the study of seven-membrane-segment receptors. Ann. Rev. Biochem. 60, 653–688.
Dubyak, G.R. and El-Moatassim, C. (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265, C577–C606.
El-Moatassim, C. and Dubyak, G. R. (1992) A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1.2F5 macrophages. J. Biol. Chem. 267, 23, 664–723, 673.
Erb, L., Lustig, K. D., Ahmed, A. H., Gonzalez, F. A., and Weisman, G. A. (1990) Covalent incorporation of 3′-O-(4-benzoyl) benzoyl ATP into a P2 purinoceptor in transformed mouse fibroblasts. J. Biol. Chem. 265, 7424–7431.
Erb, L., Lustig, K. D., Sullivan, D. M., Turner, J. T., and Weisman, G. A. (1993) Functional expression and photoaffinity labeling of a cloned P2u purinergic receptor. Proc. Natl. Acad. Sci. USA 90, 10, 449–510, 453.
Erb, L., Garrad, R., Wang, Y., Quinn, T., Turner, J. T., and Weisman, G. A. (1995) Site-directed mutagenesis of P2U purinoceptors: positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity. J. Biol. Chem. 270, 4185–4188.
Filtz, T. M., Li, Q., Boyer, J. L., Nicholas, R. A., and Harden, T. K. (1994) Expression of a cloned P2Y purinergic receptor that couples to phospholipase C. Mol. Pharmacol. 46, 8–14.
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P., and Williams, M. (1994) Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46, 143–156.
Gonzalez, F. A., Ahmed, A. H., Lustig, K. D., Erb, L., and Weisman, G. A. (1989) Study of the ATP4- receptor-mediated permeabilization of transformed mouse fibroblasts and its desensitization. J. Cell. Physiol. 139, 109–115.
Gonzalez, F. A., Wang, D. J., Huang, N. N., and Heppel, L. A. (1990) Activation of early events of the mitogenic response by a P2Y purinoceptor with covalently bound 3′-O-(4-benzoyl)-benzoyladenosine 5′-triphosphate. Proc. Natl. Acad. Sci. USA 87, 9717–9721.
Gonzalez, F. A., Raden, D. L., and Davis, R. J. (1991) Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem. 266, 22, 159–222, 163.
Gresik, E. W. (1980) Postnatal developmental changes in submandibular glands of rats and mice. J. Histochem. Cytochem. 28, 860–870.
Harden, T. K., Boyer, J. L., and Nicholas, R. A. (1995) P2-purinergic receptors: subtype-associated signaling responses and structure. Ann. Rev. Pharmacol. Toxicol. 35, 541–579.
Henderson, D. J., Elliot, D. G., Smith, G. M., Webb, T. E., and Dainty, I. A. (1995) Cloning and characterisation of a bovine P2Y receptor. Biochem. Biophys. Res. Commun. 212, 648–656.
Humphreys-Beher, M. G. (1993) Control of cell growth and proliferation, in Biology of the Salivary Glands (Dobrosielski-Vergona, K., ed.), CRC Press, Boca Raton, FL, pp. 239–262.
Janssens, R., Communi, D., Pirotton, S., Samson, M., Parmentier, M., and Boeynaems, J.-M. (1996) Cloning and tissue distribution of the human P2Y1 receptor. Biochem. Biophys. Res. Commun. 221, 588–593.
Kaplan, M. H., Smith, D. I., and Sundick, R. S. (1993) Identification of a G protein coupled receptor induced in activated T cells. J. Immunol. 151, 628–636.
Kennelly, P. J. and Krebs, E. G. (1991) Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J. Biol. Chem. 266, 15, 555–615, 558.
Knowles, M. R., Clarke, L. L., and Boucher, R. C. (1991) Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N. Engl. J. Med. 325, 533–538.
Koshiba, M., Apasov S., Sverdlov, V., Chen, P., Erb, L., Turner, J. T., Weisman, G. A., and Sitkovsky M. V. (1997) Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. Proc. Natl. Acad. Sci. USA 94, 831–836.
Lazarowski, E. R. and Harden, T. K. (1994) Identification of a uridine nucleotide-selective G-protein-linked receptor that activates phospholipase C. J. Biol. Chem. 269, 11, 830–911, 836.
Lazarowski, E. R., Watt, W. C., Stutts, M. J., Brown, H. A., Boucher, R. C., and Harden, T. K. (1995) Enzymatic synthesis of UTP7S, a potent hydrolysis resistant agonist of P2u-purinergic receptors. Br. J. Pharmacol. 117, 203–209.
Lin, T. A., Lustig, K. D, Sportiello, M. G., Weisman, G.A., and Sun, G.Y. (1993) Signal transduction pathways coupled to nucleotide receptors in neuroblastoma x glioma (NG108-15) cells. J. Neurochem. 60, 1115–1125.
Lustig, K. D., Shiau, A. K., Brake, A. J., and Julius, D. (1993) Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. USA 90, 5113–5117.
Martin, K. A., Kertesy, S. B., and Dubyak, G. R. (1997) Down-regulation of P2u-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. Mol. Pharmacol. 51, 97–108.
Mason, S. J., Paradiso, A. M., and Boucher, R. C. (1991) Regulation of transepithelial ion transport and intracellular calcium by extracellular adenosine triphosphate in human normal and cystic fibrosis airway epithelium. Br. J. Pharmacol. 103, 1649–1656.
Nguyen, T., Erb, L., Weisman, G. A., Marchese, A., Heng, H. H. Q., Garrad, R. C., George, S. R., Turner, J. T., and O’Dowd, B. F. (1995) Cloning, expression and chromosomal localization of the uridine nucleotide receptor gene. J. Biol. Chem. 270, 30, 845–930, 848.
Nicholas, R. A., Watt, W. C., Lazarowski, E. R., Li, Q., and Harden, T. K. (1966) Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: Identification of a UDP-selective, a UTP-selective, and an ATP-and UTP-specific receptor. Mol. Pharmacol. 50, 224–229.
Park, M., Garrad, R. C., Weisman, G. A., and Turner, J. T. (1997) Changes in P2Y1 nucleotide receptor activity during the development of rat salivary glands. Am. J. Physiol. 272, C1388–C1393.
Parr, C. E., Sullivan, D. M., Paradiso, A. M., Lazarowski, E. R., Burch, L. H., Olsen, J. C., Erb, L., Weisman, G. A., Boucher, R. C., and Turner, J. T. (1994) Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc. Natl. Acad. Sci. USA 91, 3275–3279.
Rice, W. R., Burton, F. M., and Fiedeldey, D. T. (1995) Cloning and expression of the alveolar type II cell P2u-purinergic receptor. Am. J. Resp. Cell. Mol. Biol. 12, 27–32.
Schachter, J. B., Li, Q., Boyer, J. L., Nicholas, R. A., and Harden, T. K. (1996) Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br. J. Pharmacol. 118, 167–173.
Soltoff, S. P., McMillian, M. K., and Talamo, B. R. (1992) ATP activates a cation-permeable pathway in rat parotid acinar cells. Am. J. Physiol. 262, C934–C940.
Stam, N. J., Klomp, J., van de Heuvel, M., and Olijve, W. (1996) Molecular cloning and characterization of a novel orphan receptor (P2p) expressed in human pancreas that shows high structural homology to the P2U purinoceptor. FEBS Lett. 384, 260–264.
Tokuyama, Y., Hara, M., Jones, E. M. C., Fan, Z., and Bell, G. I. (1995) Cloning of rat and mouse P2Y purinoceptors. Biochem. Biophys. Res. Commun. 211, 211–218.
van Rhee, A. M., Fischer, B., van Galen, P. J. M., and Jacobson, K. A. (1995) Modelling the P2y purinoceptor using rhodopsin as template. Drug Design Discov. 13, 133–154.
Webb, T. E., Simon, J., Krishek, B. J., Bateson, A. N., Smart, T. G., King, B. F., Burnstock, G., and Barnard, E. A. (1993) Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 324, 219–225.
Webb, T. E., Simon, J., Bateson, A. N., and Barnard, E. A. (1994) Transient expression of the recombinant chick brain P2y1 purinoceptor and localization of the corresponding mRNA. Cell Mol. Biol. 40(3), 437–442.
Webb, T. E., Kaplan, M. G., and Barnard, E. A. (1996a) Identification of 6H1 as a P2Y purinoceptor: P2Y5. Biochem. Biophys. Res. Commun. 219, 105–110.
Webb, T. E., Henderson, D., King, B. F., Wang, S., Simon, J., Bateson, A. N., Burn-stock, G., and Barnard, E. A. (1996b) A novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates. Mol. Pharmacol. 50, 258–265.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Weisman, G.A., Gonzalez, F.A., Erb, L., Garrad, R.C., Turner, J.T. (1998). The Cloning and Expression of G Protein-Coupled P2Y Nucleotide Receptors. In: Turner, J.T., Weisman, G.A., Fedan, J.S. (eds) The P2 Nucleotide Receptors. The Receptors. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1800-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1800-5_3
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-7289-2
Online ISBN: 978-1-4612-1800-5
eBook Packages: Springer Book Archive